Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Namisol in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain
NCT01551511Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in abdominal pain and chronic pancreatitis (CP) comparing delta-9-tetrahydrocannabinol (namisol) with Placebo (2 arms). Primary endpoint: Average Visual Analog Scale for pain at day 52. Started Oct 2012; status: completed.
02
Drugs
dronabinol
03
Conditions
abdominal painchronic pancreatitis (CP)
Beyond the preview
Go deeper on NCT01551511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01551511.